Cancer Neurology in Clinical Practice 2017
DOI: 10.1007/978-3-319-57901-6_8
|View full text |Cite
|
Sign up to set email alerts
|

Headache as Complication of Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 42 publications
0
1
0
Order By: Relevance
“…11 Overall, the successful management of headaches requires a careful review of the features and location of the headache and any exacerbating and alleviating factors, and evaluating the patient's medications, sleep quality, and other comorbidities. 12 Unfortunately, there have been no specific studies looking at prophylactic agents in this patient population; thus, management is extrapolated from the general headache population, where oral preventative medications include the classes of beta-blockers, angiotensin receptor blockers, antiseizure drugs, and antidepressants. 13 Nonsteroidal anti-inflammatory drugs and acetaminophen may be a mainstay for abortive therapy, but the risk of intracranial hemorrhage, overuse syndrome, or rebound headache should be considered.…”
Section: Headachementioning
confidence: 99%
“…11 Overall, the successful management of headaches requires a careful review of the features and location of the headache and any exacerbating and alleviating factors, and evaluating the patient's medications, sleep quality, and other comorbidities. 12 Unfortunately, there have been no specific studies looking at prophylactic agents in this patient population; thus, management is extrapolated from the general headache population, where oral preventative medications include the classes of beta-blockers, angiotensin receptor blockers, antiseizure drugs, and antidepressants. 13 Nonsteroidal anti-inflammatory drugs and acetaminophen may be a mainstay for abortive therapy, but the risk of intracranial hemorrhage, overuse syndrome, or rebound headache should be considered.…”
Section: Headachementioning
confidence: 99%